Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bernardeschi

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Thyroid metastases from colon cancer case report in a long term survivorS Rossi, G Fiorentini, G Porcu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117)G Fiorentini, S Rossi, G Lanzanova, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasoneP Bernardeschi, P Dentico, S Rossi, et al.
In Vivo (Athens, Greece)|January 6, 2007
Thalidomide plus monthly high-dose dexamethasone in chemorefractory myeloma. Results of a phase II clinical studyP Bernardeschi, G Giustarini, I Montenora, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trialG Fiorentini, S Rossi, G Lanzanova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Pulmonary hypertension related to thalidomide therapy in refractory multiple myelomaE Antonioli, C Nozzoli, G Gianfaldoni, et al.
Journal of Chemotherapy (Florence, Italy)|August 28, 2004
Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II studyG Fiorentini, S Rossi, F Bonechi, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicinG Fiorentini, P Bernardeschi, M De Simone, et al.
Leukemia|March 14, 2008
Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case recordsP Bernardeschi, G Fiorentini, P Dentico, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical studyG Fiorentini, D B Poddie, M Cantore, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Thyroid metastases from colon cancer case report in a long term survivorS Rossi, G Fiorentini, G Porcu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117)G Fiorentini, S Rossi, G Lanzanova, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasoneP Bernardeschi, P Dentico, S Rossi, et al.
In Vivo (Athens, Greece)|January 6, 2007
Thalidomide plus monthly high-dose dexamethasone in chemorefractory myeloma. Results of a phase II clinical studyP Bernardeschi, G Giustarini, I Montenora, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trialG Fiorentini, S Rossi, G Lanzanova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Pulmonary hypertension related to thalidomide therapy in refractory multiple myelomaE Antonioli, C Nozzoli, G Gianfaldoni, et al.
Journal of Chemotherapy (Florence, Italy)|August 28, 2004
Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II studyG Fiorentini, S Rossi, F Bonechi, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2006
Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicinG Fiorentini, P Bernardeschi, M De Simone, et al.
Leukemia|March 14, 2008
Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case recordsP Bernardeschi, G Fiorentini, P Dentico, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical studyG Fiorentini, D B Poddie, M Cantore, et al.
Pageof 4